Founded in 2017, the idea for Gelteq was born out of the necessity for a practical delivery method for individuals facing difficulties with swallowing, known as dysphagia. These challenges in swallowing can result in patients not adhering to their treatment plans, leading to potential long-term health complications.
Our expertise lies in formulating, developing, and manufacturing products using our patented, gel-based oral drug delivery system. Gels address numerous drawbacks commonly associated with oral delivery methods, such as swallowing difficulties, taste issues, and concerns about dosage and effectiveness.
At Gelteq, our primary focus centers on thriving markets where our technology can make a genuine impact. The pharmaceutical, nutraceutical, and animal health sectors all stand to gain significant benefits from our gel-based delivery systems.